Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy

Epilepsy and Behavior

Volumn 36, Issue , 2014, Pages 68-73

  Gouveia, T L F ^a   Scorza, F A ^a   Iha, H A ^a   Frangiotti, M I B ^a   Perosa, S R ^a   Cavalheiro, E A ^a   Silva, J A ^b   Feliciano, R S ^b   de Almeida, A C ^c   Naffah Mazzacoratti, M G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

Cytokines; Epileptogenesis; Lovastatin; Pilocarpine; Temporal lobe epilepsy

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MEVINOLIN; PILOCARPINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; HYPOCHOLESTEROLEMIC AGENT; MUSCARINIC AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EPILEPTOGENESIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TEMPORAL LOBE EPILEPSY; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EPILEPSY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TOXICITY; WISTAR RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; EPILEPSY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LOVASTATIN; MALE; MUSCARINIC AGONISTS; PILOCARPINE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 84901236081     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.04.009     Document Type: Article

References (42)

1. Pitkanen A., Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002, 1(3):173-181.
2. Choi H., Sell R.L., Lenert L., Muennig P., Goodman R.R., Gilliam F.G., et al. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA 2008, 300(21):2497-2505.
3. Ravizza T., Vezzani A. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 2006, 137(1):301-308.
4. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46(11):1724-1743.
5. Arganaraz G., Regina Perosa S., Cristina Lencioni E., Bader M., Abrao Cavalheiro E., Da Graca Naffah-Mazzacoratti M., et al. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy. Brain Res 2004, 1013(1):30-39.
6. Arganaraz G.A., Silva J.A., Perosa S.R., Pessoa L.G., Carvalho F.F., Bascands J.L., et al. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Brain Res 2004, 1006(1):114-125.
7. Gouveia T.L., Scorza F.A., Silva M.J., Bandeira Tde A., Perosa S.R., Arganaraz G.A., et al. Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus. Epilepsy Behav 2011, 20(1):1-5.
8. Perosa S.R., Arganaraz G.A., Goto E.M., Costa L.G., Konno A.C., Varella P.P., et al. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy. Hippocampus 2007, 17(1):26-33.
9. Silva J.A., Goto E.M., Perosa S.R., Argañaraz G.A., Cavalheiro E.A., Naffah-Mazzacoratti M.G., et al. Kinin B1 receptors facilitate the development of temporal lobe epilepsy in mice. Int Immunopharmacol 2008, 8(2):197-199.
10. Varella P.P., Santiago J.F., Carrete H., Higa E.M., Yacubian E.M., Centeno R.S., et al. Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis. Arq Neuropsiquiatr 2011, 69(1):91-99.
11. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12(7):2623-2633.
12. Ginsberg H.N. Effects of statins on triglyceride metabolism. Am J Cardiol 1998, 81(4A):32B-35B.
13. Griffin J.L., Nicholls A.W. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006, 7(7):1095-1107.
14. Li G., Larson E.B., Sonnen J.A., Shofer J.B., Petrie E.C., Schantz A., et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007, 69(9):878-885.
15. Cimino M., Gelosa P., Gianella A., Nobili E., Tremoli E., Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 2007, 13(3):208-213.
16. Neuhaus O., Stuve O., Zamvil S.S., Hartung H.P. Are statins a treatment option for multiple sclerosis?. Lancet Neurol 2004, 3(6):369-371.
17. Rangel P., Cysneiros R.M., Arida R.M., De Albuquerque M., Colugnati D.B., Scorza C.A., et al. Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results. Arq Neuropsiquiatr 2005, 63(4):972-976.
18. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 1983, 9(3):315-335.
19. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1991, 32:778-782.
20. Zacco A., Togo J., Spence K., Ellis A., Lloyd D., Furlong S., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 2003, 23(35):11104-11111.
21. Mctaggart F., Buckett L., Davidson R., Holdgate G., Mccormick A., Schneck D., et al. Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol 2001, 87(5A):28B-32B.
22. Chen C., Mireles R.J., Campbell S.D., Lin J., Mills J.B., Xu J.J., et al. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Drug Metab Dispos 2005, 33(4):537-546.
23. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003, 53(6):743-751.
24. Lu D., Mahmood A., Goussev A., Schallert T., Qu C., Zhang Z.G., et al. Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg 2004, 101(5):813-821.
25. Lu D., Qu C., Goussev A., Jiang H., Lu C., Schallert T., et al. Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma 2007, 24(7):1132-1146.
26. Hering H., Lin C.C., Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 2003, 23(8):3262-3271.
27. Kirsch C., Eckert G.P., Mueller W.E. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 2003, 65(5):843-856.
28. Wang Y., Qin Z.-H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010, 15(11):1382-1402.
29. Dolga A.M., Nijholt I.M., Ostroveanu A., Ten Bosch Q., Luiten P.G., Eisel U.L. Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways. J Alzheimers Dis 2008, 13(2):111-122.
30. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002, 22(7):RC216.
31. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U.L. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 2004, 279(31):32869-32881.
32. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. Interleukin-10 provides direct trophic support to neurons. J Neurochem 2009, 110(5):1617-1627.
33. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281(5381):1305-1308.
34. Pahan K., Khan M., Singh I. Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase. J Neurochem 2000, 75(2):576-582.
35. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001, 21(9):3104-3112.
36. Strle K., Zhou J.H., Broussard S.R., Venters H.D., Johnson R.W., Freund G.G., et al. IL-10 promotes survival of microglia without activating Akt. J Neuroimmunol 2002, 122(1-2):9-19.
37. Brodie C. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes. FEBS Lett 1996, 394(2):117-120.
38. Grilli M., Barbieri I., Basudev H., Brusa R., Casati C., Lozza G., et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 2000, 12:2265-2272.
39. Agnello D., Villa P., Ghezzi P. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice. Brain Res 2000, 869:241-243.
40. Sewnath M.E., Olszyna D.P., Birjmohun R., ten Kate F.J., Gouma D.J., van Der Poll T. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 2001, 166:6323-6331.
41. Schobitz B., De Kloet E.R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 1994, 44:397-432.
42. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263:C1-16.